tiprankstipranks
Trending News
More News >
Ultragenyx Pharmaceutical (RARE)
NASDAQ:RARE
US Market

Ultragenyx Pharmaceutical (RARE) Cash flow

Compare
1,087 Followers

Ultragenyx Pharmaceutical Cash Flow

RARE's free cash flow for Q3 2025 was $-92.70M. For the 2025 fiscal year, RARE's free cash flow was decreased by $99.89M and operating cash flow was $-91.42M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -414.19M$ -474.81M$ -380.46M$ -338.69M$ -132.22M
Investing Cash Flow
$ -17.77M$ 168.00M$ -291.65M$ -195.37M$ -179.12M
Financing Cash Flow
$ 399.24M$ 388.14M$ 501.21M$ 118.55M$ 600.27M
End Cash Position
$ 184.16M$ 219.40M$ 137.60M$ 309.58M$ 726.29M
Free Cash Flow
$ -421.68M$ -521.57M$ -526.59M$ -411.79M$ -176.13M
Currency in USD

Ultragenyx Pharmaceutical Cash Flow